Abytiga 250mg Tablet contains Abiraterone Acetate, a medication used in the treatment of prostate cancer. It works by inhibiting the production of androgens (male hormones) that can promote the growth of prostate cancer cells. Typically prescribed alongside prednisone, Abytiga helps slow disease progression and improve patient outcomes. Regular use under medical supervision is essential to ensure effectiveness and minimize side effects.

Uses

• Treats advanced or metastatic prostate cancer

• Reduces androgen production

• Slows tumor growth

• Supports hormonal therapy for prostate cancer

• Improves overall cancer management outcomes

Benefits

• Helps control progression of prostate cancer

• Reduces cancer-related symptoms

• Supports overall patient quality of life

• Works effectively with prednisone for hormone suppression

• Enhances treatment outcomes when used as prescribed

Dosage

• As prescribed by doctor

• Typically 250mg once daily

• Take on an empty stomach with water

• Usually combined with prednisone as directed

• Follow doctor’s schedule strictly for best results

Alternate Product

• Zytiga 250mg Tablets

• Abirapro 250mg Tablets

Side Effects

• Fatigue and weakness

• Nausea or vomiting

• Fluid retention or swelling

• High blood pressure or liver enzyme changes

• Rare allergic reactions

FAQs

Q1: Who should take Abytiga 250mg Tablet?

Patients with advanced or metastatic prostate cancer under medical supervision.

Q2: Can it be taken with food?

No — take on an empty stomach for proper absorption.

Q3: Are there common side effects?

Fatigue, nausea, fluid retention, and high blood pressure may occur.

Q4: Can it be used with other cancer medications?

Yes, but only under strict doctor guidance.

Q5: How long should it be taken?

As prescribed by your oncologist — long-term use depends on disease status.

Q6: How should it be stored?

Store in a cool, dry place away from sunlight and children.

Q7: Can it affect liver function?

Yes — regular liver function tests are recommended during therapy.